RUSSO, Diego
 Distribuzione geografica
Continente #
NA - Nord America 7.482
AS - Asia 5.118
EU - Europa 1.659
SA - Sud America 1.206
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 112
OC - Oceania 9
Totale 15.775
Nazione #
US - Stati Uniti d'America 7.203
SG - Singapore 2.371
CN - Cina 1.244
BR - Brasile 929
IT - Italia 713
VN - Vietnam 592
IN - India 476
SE - Svezia 292
GB - Regno Unito 193
DE - Germania 173
CA - Canada 167
AR - Argentina 112
BD - Bangladesh 98
HK - Hong Kong 68
MX - Messico 61
FI - Finlandia 59
EC - Ecuador 57
TR - Turchia 56
ID - Indonesia 40
IQ - Iraq 30
RU - Federazione Russa 30
ZA - Sudafrica 28
ES - Italia 27
UA - Ucraina 27
CO - Colombia 24
NL - Olanda 24
PY - Paraguay 22
FR - Francia 19
IR - Iran 18
JP - Giappone 18
PK - Pakistan 18
PL - Polonia 18
CL - Cile 16
MA - Marocco 16
VE - Venezuela 16
RO - Romania 15
DZ - Algeria 13
EE - Estonia 13
UY - Uruguay 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
JM - Giamaica 11
KE - Kenya 11
PE - Perù 11
DO - Repubblica Dominicana 10
TN - Tunisia 10
IE - Irlanda 9
ET - Etiopia 8
GR - Grecia 8
SA - Arabia Saudita 8
BO - Bolivia 7
JO - Giordania 7
AU - Australia 6
BE - Belgio 6
CR - Costa Rica 6
HN - Honduras 6
IL - Israele 6
KR - Corea 6
AT - Austria 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
GT - Guatemala 4
SV - El Salvador 4
BH - Bahrain 3
DK - Danimarca 3
EU - Europa 3
HR - Croazia 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
SC - Seychelles 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
DM - Dominica 1
GN - Guinea 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
Totale 15.580
Città #
San Jose 1.237
Chandler 778
Dallas 662
Ashburn 600
Singapore 600
Santa Clara 441
Hefei 373
Bengaluru 372
Lawrence 360
Princeton 360
Milan 356
Council Bluffs 335
Ho Chi Minh City 220
Wilmington 197
Beijing 157
Chicago 153
London 148
Hanoi 121
Munich 120
Ottawa 119
Des Moines 118
São Paulo 76
Hong Kong 67
Boardman 66
Shanghai 59
Los Angeles 54
Turku 46
New York 44
Catanzaro 42
Haiphong 38
Norwalk 37
Rio de Janeiro 33
Guangzhou 29
Da Nang 28
Brooklyn 26
Shenzhen 25
Rome 23
Redwood City 22
Mexico City 21
Pune 21
Chennai 20
San Francisco 20
Guayaquil 19
Curitiba 18
Quito 18
Thái Bình 18
Boston 17
Hanover 17
Istanbul 17
Phoenix 16
Brasília 15
Jiaxing 15
Montreal 15
Washington 15
Atlanta 14
Belo Horizonte 14
Ninh Bình 14
Porto Alegre 14
Seattle 14
Ankara 13
Campinas 13
Johannesburg 13
Biên Hòa 12
Orem 12
Redmond 12
Tokyo 12
Toronto 12
Warsaw 12
Baghdad 11
Delhi 11
Helsinki 11
Manaus 11
Salvador 11
Buffalo 10
Dhaka 10
Horia 10
Hortolândia 10
Montevideo 10
Nairobi 10
Stockholm 10
Ann Arbor 9
Fortaleza 9
Houston 9
Hải Dương 9
Jakarta 9
Quanzhou 9
Tashkent 9
Xi'an 9
Abu Dhabi 8
Bauru 8
Buenos Aires 8
Catania 8
Columbus 8
Guarulhos 8
Kingston 8
Naples 8
Nottingham 8
Ribeirão Preto 8
Rui'an 8
Santo André 8
Totale 9.298
Nome #
Biological Activity of Oleuropein and Its Derivatives 185
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy 122
Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells 92
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 92
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 92
Hashimoto's thyroiditis and vestibular dysfunction 91
Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells 89
A case of metastatic medullary thyroid carcinoma: early identification before surgery of a ret proto-oncogene somatic mutation in fine needle aspirate specimen 88
Precision oncology for RET-related tumors 87
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 86
Antiproliferative activity of PDE5 inhibitors vehicled by nanovescicles in thyroid cancer cells. 85
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 84
Antiproliferative effects afforded by pyrazolopyrimidine derivates on human neuroblastoma cells 83
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 83
IL-20 Subfamily Biological Effects: Mechanistic Insights and Therapeutic Perspectives in Cancer 82
A novel mutation in the thyrotropin receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistence to TSH 82
Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells 80
A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor 79
Anti-hTERT siRNA nanoparticles block the growth of anaplastic thyroid cancer cells in vitro and in vivo. 79
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 79
A novel mutation in the Thyrotropin receptor gene causing loss of TSH binding but constitutive activation in a family with resistance to TSH 78
A Phe 486 TSH receptor mutation in a autonomously functioning follicular carcinoma that was causing hyperthyroidism 78
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 78
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 76
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 76
Absence od Sodium/Iodide symporter gene mutations in differentiated human thyroid carcinomas 75
Antiproliferative and antioxidant effects of oleuropein and its semisynthetic peracetylated derivatives on breast cancer cells 75
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 74
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes 73
Activating mutations of the TSH Receptor in differentiated thyroid carcinomas 72
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 70
Expression and cellular localization of Ref-1 in human thyroid carcinoma cell lines 69
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 68
Antiproliferative activity of PDE5 inhibitors vehicled by nanovesicles in thyroid cancer cells 68
Antioxidant and antiproliferative effects of olive-leaf extract oleuropein and its peracetylated derivate on human thyroid cancer cells 68
A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens 68
Adenyl cyclase activity and Gs and Gi alpha ADP-ribosylation in thyroid hyperfunctioning adenomas presenting TSH receptor or Gsp mutations 67
TSH-CONJUGATED NANOCARRIER FOR THE TREATMENT OF THYROID CANCER 67
Antiproliferative activity of PDE5 inhibitors vehicle by nanovesicles in thyroid cancer cells. 67
Antiproliferative Effects of Two Pyrazolo-Pyrimidine Derivates on Human Anaplastic Thyroid Cancer Cells 67
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma. 66
A new structural model for the Thyrotropin receptor as determined by covalent crosslinking of Thyrotropin to the recombinant receptor in intact cells: evidence for a single polypeptide chain. 65
Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice 65
A call to action: Now is the time to screen elderly and treat osteosarcopenia, a position paper of the italian college of academic nutritionists med/49 (ican-49) 65
Absence of iodide symporter gene mutations in human thyroid tumors 64
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 63
Evaluation of biological effects of TERT inhibition in human thyroid cancer cells 63
Epigenetic-related gene expression profile in Medullary Thyroid Cancer revealed the overexpression of the Histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 63
A novel germline VHL gene mutation in two different patients with pheochromocytoma. 63
Antiproliferative effects of olive-leaf extract oleuropein and derivatives in human breast cancer cells 63
Carcinomi differenziati della tiroide: ruolo oncogenico del recettore del TSH 61
Analisi della proteina APE/Ref-1 nei noduli tiroidei iperfunzionanti: aumento dell’espressione nelle frazioni nucleari 61
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 60
MicroRNAs as Biomarkers in Thyroid Carcinoma 59
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 58
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAFV600E mutation 58
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules 58
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 58
Ape1/Ref-1 is increased in nuclear fractions of human thyroid hot nodules 57
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 56
Functional analysis of the cytoplasmic domains of the human TSH receptor by site-directed mutagenesis. 56
NANOVETTORE CONIUGATO CON TSH PER IL TRATTAMENTO DEL CANCRO DELLA TIROIDE 56
Carcinoma midollare della tiroide: identificazione di una nuova mutazione 56
Expression of YAP1 in aggressive thyroid cancer 56
Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells 56
Functional interaction among thyroid specific transcription factors: PAX8 regulates the activity of Hex promoter 55
Genetic analysis in fine needle aspiration of the thyroid: a new tool for clinic 55
Expression of adenylyl cyclase types III and VI in human hyperfunctioning thyroid nodules 55
Normocaloric Diet Restores Weight Gain and Insulin Sensitivity in Obese Mice 55
Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells 55
Maggisano V., Capriglione F., Mio C., Bulotta S., Damante G., Russo D., Celano M 54
Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine 54
Alterazioni del trasportatore dello iodio in patologia tiroidea 54
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 54
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes. 54
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. 54
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches. 53
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency. 53
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 53
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. 52
Genetica molecolare delle tireopatie 52
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 52
Safety Evaluation of Subchronic Oral Administration of Oleuropein and its Semisynthetic Peracetylated Derivative 52
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells 51
Control of PTEN gene expression in normal and neoplastic thyroid cells 51
Identification of thyroid-associated serum microrna profiles and their potential use in thyroid cancer follow-up 51
Expression of leptin receptor and effects of leptin on papillary thyroid carcinoma cells 51
BRAF V600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas 51
Aqueous–core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response 51
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity 51
Analysis of YAP1 expression in papillary thyroid cancer, lymph node metastases and medullary thyroid cancer. 51
B-RAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 51
Identification of novel molecular target for the treatment of thyroid cancers. 51
Detection of an activating mutation of the TSH receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 51
A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism 51
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivate 50
Absence of Sodium-Iodide Symporter gene mutations in differentiated human thyroid carcinomas 50
Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL-5 rat thyroid cells 50
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfuctioning nodules 50
Genetic analysis in fine needle aspiration biopsy of the thyroid: a new tool for the clinic. 50
Totale 6.608
Categoria #
all - tutte 170.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022869 0 3 7 185 117 11 37 210 80 59 147 13
2022/20232.398 738 98 73 186 246 204 5 174 351 135 146 42
2023/2024834 164 142 57 43 49 229 13 36 16 17 12 56
2024/20253.321 551 316 155 180 123 415 24 87 450 286 227 507
2025/20267.372 243 925 961 1.549 686 222 837 503 830 377 157 82
2026/2027439 76 363 0 0 0 0 0 0 0 0 0 0
Totale 15.775